A medium-sized pharmaceutical company approached Southern Research to test the efficacy of their therapeutic molecules against highly pathogenic MPXV, Zaire strain in non-human primates (NHPs).
Therapeutic Areas:
IDR
Capabilities:
Animal Models
,
Chemistry
,
Therapeutic Modalities
Related Resources
Related Resource block to be added later.
Ready to Advance Your Research?
Contact our experts today and explore how Southern Research can elevate your project.